HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Tempel-Brami Selected Research

Hepatocellular Carcinoma (Hepatoma)

2/2023Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959.
6/2022Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Tempel-Brami Research Topics

Disease

7Neoplasms (Cancer)
02/2023 - 02/2002
2Hepatocellular Carcinoma (Hepatoma)
02/2023 - 06/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022
1Fanconi Anemia (Fanconi's Anemia)
10/2021
1Malignant Mesothelioma
10/2021
1Seizures (Absence Seizure)
07/2013
1Cognitive Dysfunction
02/2012
1Hemorrhagic Stroke
02/2012
1Alzheimer Disease (Alzheimer's Disease)
02/2012
1Amyloidosis
02/2012
1Wounds and Injuries (Trauma)
12/2011
1Necrosis
04/2010
1Vascular Remodeling
02/2002

Drug/Important Bio-Agent (IBA)

2Sorafenib (BAY 43-9006)FDA Link
02/2023 - 06/2022
2Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2021
2Antimitotic AgentsIBA
06/2022 - 10/2021
1Immune Checkpoint InhibitorsIBA
11/2022
1B7-H1 AntigenIBA
11/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1Cisplatin (Platino)FDA LinkGeneric
10/2021
1Pemetrexed (MTA)FDA Link
10/2021
1PlatinumIBA
10/2021
1Oxygen (Dioxygen)IBA
07/2013
1Amyloid (Amyloid Fibrils)IBA
02/2012
1Explosive Agents (Explosives)IBA
12/2011
1palladium-bacteriopheophorbideIBA
04/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2002
1PMSG-HCGIBA
02/2002

Therapy/Procedure

2Therapeutics
10/2021 - 04/2010
1Combined Modality Therapy
06/2022
1Drug Therapy (Chemotherapy)
10/2021
1Immunotherapy
02/2012
1Photochemotherapy (Photodynamic Therapy)
04/2010